Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Lysozyme Chloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Ncgc00181761-01
    Molecular Formula
    C36H61N7O19
    Molecular Weight
    895.9  g/mol
    InChI Key
    DTYZSEFHBLCMTE-HDIZBSAMSA-N
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2R)-2-[[(2S)-6-amino-2-[[(4R)-5-amino-4-[[(2S)-2-[2-[(3R,4R,5S,6R)-3-(carboxyamino)-5-[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoyl]amino]-5-oxopentanoyl]amino]hexanoyl]amino]propanoic acid
    2.1.2 InChI
    InChI=1S/C36H61N7O19/c1-14(46)11-18-25(48)26(49)21(12-44)61-35(18)62-27-22(13-45)60-34(56)24(43-36(57)58)28(27)59-17(4)31(52)39-15(2)30(51)42-19(29(38)50)8-9-23(47)41-20(7-5-6-10-37)32(53)40-16(3)33(54)55/h15-22,24-28,34-35,43-45,48-49,56H,5-13,37H2,1-4H3,(H2,38,50)(H,39,52)(H,40,53)(H,41,47)(H,42,51)(H,54,55)(H,57,58)/t15-,16+,17?,18+,19+,20-,21+,22+,24+,25+,26+,27+,28+,34?,35-/m0/s1
    2.1.3 InChI Key
    DTYZSEFHBLCMTE-HDIZBSAMSA-N
    2.1.4 Canonical SMILES
    CC(C(=O)NC(CCC(=O)NC(CCCCN)C(=O)NC(C)C(=O)O)C(=O)N)NC(=O)C(C)OC1C(C(OC(C1OC2C(C(C(C(O2)CO)O)O)CC(=O)C)CO)O)NC(=O)O
    2.1.5 Isomeric SMILES
    C[C@@H](C(=O)N[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C)C(=O)O)C(=O)N)NC(=O)C(C)O[C@H]1[C@@H]([C@H](OC([C@@H]1NC(=O)O)O)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)CC(=O)C
    2.2 Synonyms
    2.2.1 Depositor-Supplied Synonyms

    1. Ncgc00181761-01

    2.3 Create Date
    2008-07-11
    3 Chemical and Physical Properties
    Molecular Weight 895.9 g/mol
    Molecular Formula C36H61N7O19
    XLogP3-8.3
    Hydrogen Bond Donor Count14
    Hydrogen Bond Acceptor Count20
    Rotatable Bond Count25
    Exact Mass895.40222274 g/mol
    Monoisotopic Mass895.40222274 g/mol
    Topological Polar Surface Area427 Ų
    Heavy Atom Count62
    Formal Charge0
    Complexity1560
    Isotope Atom Count0
    Defined Atom Stereocenter Count13
    Undefined Atom Stereocenter Count2
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1